Market Overview:
The global life sciences contract research outsourcing market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The market growth is attributed to the increasing demand for contract research services from academic medical centers, clinical trial laboratories, and contract research organizations (CROs). In addition, the growing demand for drug discovery services, clinical data management services, and regulatory services are also contributing to the growth of the life sciences contract research outsourcing market. However, stringent regulatory requirements and lack of skilled professionals are restraining the growth of this market. On the basis of application type; academic medical centers accounted for majority share in 2017 owing to rising number of collaborations between pharmaceutical companies and universities for conducting preclinical studies and early-stage clinical trials.
Product Definition:
Life Sciences Contract Research Outsourcing is the contracting out of specific services or functions within the life sciences sector to a third party. The purpose of this type of outsourcing is to gain access to specialized skills, knowledge, or resources that are not available internally. Life sciences contract research organizations can provide a wide range of services, including drug discovery and development, clinical trials management, regulatory affairs support, and manufacturing.
Drug Discovery:
The global drug discovery market size was valued at USD 25.6 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The increasing R&D cost, growing need for new drugs, and patent expiration of existing drugs are the major factors driving growth in this sector.
Clinical Trials:
A clinical trial is a research study designed to test the safety and efficacy of an new medical drug or treatment. Clinical trials are conducted to evaluate the effectiveness of various therapeutic agents in treating diseases, disorders, and conditions. The primary goal of clinical research is to develop innovative products that lead to better health outcomes for patients.
The global life sciences contract research outsourcing market size was valued at USD 50 billion in 2015.
Application Insights:
The academic medical centers segment held the largest share of over 60.0% in 2017. This is attributed to presence of a large number of contract research organizations (CROs) that primarily conduct clinical trials for the development and approval of new drugs and devices at these institutions. These organizations provide various services including drug discovery, preclinical testing, phase I & II clinical trials, phase III clinical trial management services as well as data management & analysis support for various other studies such as biomarker studies or toxicology assays.
The growing emphasis on innovation by companies to develop novel products with better therapeutic potential coupled with increasing government initiatives towards implementation of guidelines promoting standardization across multiple countries is expected to increase the utilization rate for outsourcing contracts related activities such as drug discovery and late-stage development programs throughout 2018 till 2030 thereby driving growth during this period.
Regional Analysis:
North America dominated the global life sciences contract research outsourcing market in 2017. The presence of major players, increased funding for R&D activities, and high adoption rate of CROs in this region are some factors responsible for its large share. Asia Pacific is expected to grow at a lucrative CAGR during the forecast period due to increasing outsourcing opportunities offered by India and China. In addition, growing medical tourism industry in these countries is also expected to boost the demand for clinical trials conducted offshore.
The European market was valued at USD X million in 2017 owing to high-quality standards followed while conducting clinical trials within this region as well as across Europe itself has become increasingly stringent after approval of new regulatory guidelines such as Good Clinical Practice (GCP).
Growth Factors:
- Increasing demand for contract research services from the biopharmaceutical and medical device industries.
- The increasing number of late-stage drug development programs and the consequent need for outsourced clinical research services.
- The growing trend of outsourcing non-core activities to reduce costs and improve operational efficiency.
- The increasing demand for personalized medicine and companion diagnostics, which requires specialized laboratory testing services that can be provided by CROs.
Scope Of The Report
Report Attributes
Report Details
Report Title
Life Sciences Contract Research Outsourcing Market Research Report
By Type
Drug Discovery, Clinical Trials, Preclinical, Phase I Trials, Phase II Trials, Phase III Trials, Phase IV Trials, Clinical Data Management, Medical Writing Services, Regulatory Services
By Application
Academic Medical Centers, Clinical Trial Laboratories, Contract Research organizations
By Companies
Quintiles Transnational Corporation, Covance, Inc., Parexel, Omnicare Clinical Research
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Life Sciences Contract Research Outsourcing Market Report Segments:
The global Life Sciences Contract Research Outsourcing market is segmented on the basis of:
Types
Drug Discovery, Clinical Trials, Preclinical, Phase I Trials, Phase II Trials, Phase III Trials, Phase IV Trials, Clinical Data Management, Medical Writing Services, Regulatory Services
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic Medical Centers, Clinical Trial Laboratories, Contract Research organizations
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Quintiles Transnational Corporation
- Covance, Inc.
- Parexel
- Omnicare Clinical Research
Highlights of The Life Sciences Contract Research Outsourcing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Drug Discovery
- Clinical Trials
- Preclinical
- Phase I Trials
- Phase II Trials
- Phase III Trials
- Phase IV Trials
- Clinical Data Management
- Medical Writing Services
- Regulatory Services
- By Application:
- Academic Medical Centers
- Clinical Trial Laboratories
- Contract Research organizations
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Life Sciences Contract Research Outsourcing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Life Sciences Contract Research Outsourcing (LSCRO) is a contract research model in which a company outsources the research and development of new products or services to independent researchers. LSCRO can be used for a variety of products and services, including pharmaceuticals, medical devices, biotechnology products, and agricultural chemicals.
Some of the major companies in the life sciences contract research outsourcing market are Quintiles Transnational Corporation, Covance, Inc., Parexel, Omnicare Clinical Research.
The life sciences contract research outsourcing market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Life Sciences Contract Research Outsourcing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Life Sciences Contract Research Outsourcing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Life Sciences Contract Research Outsourcing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Life Sciences Contract Research Outsourcing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Life Sciences Contract Research Outsourcing Market Size & Forecast, 2018-2028
4.5.1 Life Sciences Contract Research Outsourcing Market Size and Y-o-Y Growth
4.5.2 Life Sciences Contract Research Outsourcing Market Absolute $ Opportunity
Chapter 5 Global Life Sciences Contract Research Outsourcing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Life Sciences Contract Research Outsourcing Market Size Forecast by Type
5.2.1 Drug Discovery
5.2.2 Clinical Trials
5.2.3 Preclinical
5.2.4 Phase I Trials
5.2.5 Phase II Trials
5.2.6 Phase III Trials
5.2.7 Phase IV Trials
5.2.8 Clinical Data Management
5.2.9 Medical Writing Services
5.2.10 Regulatory Services
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Life Sciences Contract Research Outsourcing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Life Sciences Contract Research Outsourcing Market Size Forecast by Applications
6.2.1 Academic Medical Centers
6.2.2 Clinical Trial Laboratories
6.2.3 Contract Research organizations
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Life Sciences Contract Research Outsourcing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Life Sciences Contract Research Outsourcing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Life Sciences Contract Research Outsourcing Analysis and Forecast
9.1 Introduction
9.2 North America Life Sciences Contract Research Outsourcing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Life Sciences Contract Research Outsourcing Market Size Forecast by Type
9.6.1 Drug Discovery
9.6.2 Clinical Trials
9.6.3 Preclinical
9.6.4 Phase I Trials
9.6.5 Phase II Trials
9.6.6 Phase III Trials
9.6.7 Phase IV Trials
9.6.8 Clinical Data Management
9.6.9 Medical Writing Services
9.6.10 Regulatory Services
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Life Sciences Contract Research Outsourcing Market Size Forecast by Applications
9.10.1 Academic Medical Centers
9.10.2 Clinical Trial Laboratories
9.10.3 Contract Research organizations
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Life Sciences Contract Research Outsourcing Analysis and Forecast
10.1 Introduction
10.2 Europe Life Sciences Contract Research Outsourcing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Life Sciences Contract Research Outsourcing Market Size Forecast by Type
10.6.1 Drug Discovery
10.6.2 Clinical Trials
10.6.3 Preclinical
10.6.4 Phase I Trials
10.6.5 Phase II Trials
10.6.6 Phase III Trials
10.6.7 Phase IV Trials
10.6.8 Clinical Data Management
10.6.9 Medical Writing Services
10.6.10 Regulatory Services
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Life Sciences Contract Research Outsourcing Market Size Forecast by Applications
10.10.1 Academic Medical Centers
10.10.2 Clinical Trial Laboratories
10.10.3 Contract Research organizations
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Life Sciences Contract Research Outsourcing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Life Sciences Contract Research Outsourcing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Life Sciences Contract Research Outsourcing Market Size Forecast by Type
11.6.1 Drug Discovery
11.6.2 Clinical Trials
11.6.3 Preclinical
11.6.4 Phase I Trials
11.6.5 Phase II Trials
11.6.6 Phase III Trials
11.6.7 Phase IV Trials
11.6.8 Clinical Data Management
11.6.9 Medical Writing Services
11.6.10 Regulatory Services
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Life Sciences Contract Research Outsourcing Market Size Forecast by Applications
11.10.1 Academic Medical Centers
11.10.2 Clinical Trial Laboratories
11.10.3 Contract Research organizations
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Life Sciences Contract Research Outsourcing Analysis and Forecast
12.1 Introduction
12.2 Latin America Life Sciences Contract Research Outsourcing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Life Sciences Contract Research Outsourcing Market Size Forecast by Type
12.6.1 Drug Discovery
12.6.2 Clinical Trials
12.6.3 Preclinical
12.6.4 Phase I Trials
12.6.5 Phase II Trials
12.6.6 Phase III Trials
12.6.7 Phase IV Trials
12.6.8 Clinical Data Management
12.6.9 Medical Writing Services
12.6.10 Regulatory Services
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Life Sciences Contract Research Outsourcing Market Size Forecast by Applications
12.10.1 Academic Medical Centers
12.10.2 Clinical Trial Laboratories
12.10.3 Contract Research organizations
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Life Sciences Contract Research Outsourcing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Life Sciences Contract Research Outsourcing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Life Sciences Contract Research Outsourcing Market Size Forecast by Type
13.6.1 Drug Discovery
13.6.2 Clinical Trials
13.6.3 Preclinical
13.6.4 Phase I Trials
13.6.5 Phase II Trials
13.6.6 Phase III Trials
13.6.7 Phase IV Trials
13.6.8 Clinical Data Management
13.6.9 Medical Writing Services
13.6.10 Regulatory Services
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Life Sciences Contract Research Outsourcing Market Size Forecast by Applications
13.10.1 Academic Medical Centers
13.10.2 Clinical Trial Laboratories
13.10.3 Contract Research organizations
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Life Sciences Contract Research Outsourcing Market: Competitive Dashboard
14.2 Global Life Sciences Contract Research Outsourcing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Quintiles Transnational Corporation
14.3.2 Covance, Inc.
14.3.3 Parexel
14.3.4 Omnicare Clinical Research
